Page last updated: 2024-09-03

omega-n-methylarginine and c-peptide

omega-n-methylarginine has been researched along with c-peptide in 1 studies

Compound Research Comparison

Studies (omega-n-methylarginine)	Trials (omega-n-methylarginine)	Recent Studies (post-2010) (omega-n-methylarginine)	Studies (c-peptide)	Trials (c-peptide)	Recent Studies (post-2010) (c-peptide)
4,411	344	336	9,053	1,632	2,445

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Johansson, BL; Pernow, J; Wahren, J	1

Trials

1 trial(s) available for omega-n-methylarginine and c-peptide

Article	Year
C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:4 Topics: Acetylcholine; Adult; Blood Flow Velocity; C-Peptide; Diabetes Mellitus, Type 1; Forearm; Humans; Infusions, Intravenous; Insulin; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilator Agents	2003

Article

Year

C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.

American journal of physiology. Endocrinology and metabolism, 2003, Volume: 285, Issue:4

Topics: Acetylcholine; Adult; Blood Flow Velocity; C-Peptide; Diabetes Mellitus, Type 1; Forearm; Humans; Infusions, Intravenous; Insulin; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasodilator Agents

2003